Skip to main content

Decision Support

By Mike Miliard | 02:06 pm | September 02, 2016
Fewer than one-third of healthcare providers polled for the newest HIMSS Analytics Essentials Brief are currently pursuing precision medicine initiatives – with the majority who don't saying that limitations in funding, technology or expertise are holding them back. But that's poised to change very soon.
By Bill Siwicki | 04:13 pm | August 31, 2016
The artificial intelligence subsidiary launched a new research partnership to reduce the amount of time it takes to plan radiotherapy treatment for certain cancers.
By Mike Miliard | 11:53 am | August 19, 2016
Stanford clinicians shine a light on how today's products are missing out on big opportunities.
By Bernie Monegain | 10:40 am | August 04, 2016
The company also said its scientists are working with Icahn School of Medicine at Mount Sinai to test the technology on prostate cancer.
By Jack McCarthy | 11:40 am | August 01, 2016
The entities are building a statewide health information network that will enable doctors to share real-time patient data and analytics. 
By Kaiser Health News | 12:01 pm | July 21, 2016
Researchers in California regularly use a database to search for trends, confirm potential cancer clusters and identify disparities in screening and outcomes.
By Bernie Monegain | 11:40 am | July 21, 2016
Scientists at Weill Cornell Medicine say the new genome sequencing test to detect mutations can guide precision cancer treatment with more than 95 percent accuracy.
By Jessica Davis | 12:28 pm | July 11, 2016
The American Heart Association is partnering with Amazon Web Services, in an effort to further cardiovascular medicine with AWS cloud technology.
By Mike Miliard | 11:40 am | June 29, 2016
Intermountain Healthcare, Stanford Cancer Institute, Providence Health & Services, Catholic Health Initiative and Henry Ford Health System have joined with precision medicine company Syapse for OPeN, the Oncology Precision Network.
By Jessica Davis | 11:58 am | June 22, 2016
Researchers from Vanderbilt University Medical Center have begun recruiting volunteers to participate in a clinical trial that will decode the immune system through the immunome – the genetic backbone of the immune system.